Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Gumlink has taken over a 50% stake in Vancouver-based probiotic and nutraceutical chewing gum manufacturer Tab Labs.
Subscribe to our email newsletter
The joint venture is among the first initiatives in Gumlink’s nutraceutical strategy for the future involving strategic collaborations with various industry partners, as announced in January this year.
Gumlink said it will reinforce the joint venture by contributing with its nutraceutical chewing gum capabilities, and the accumulated know-how in its R&D facilities located in Denmark.
To support the new venture, Chris Chilcott has joined the Tab Labs management team, to head up Tab Labs’ new Nutraceutical Innovation Center.
Gumlink CEO Soren Birn said the move will provide them with a nutraceutical manufacturing and distribution platform in North America and provide access to novel technologies that when combined with the company’s gum technologies will enable to offer the potent nutraceutical chewing gum assortment.
Tab Labs CEO Tom Holtgen said Gumlink brings scale, infrastructure and resources to their company and both of them have common vision and synergies that are very complementary, and will result in many novel innovations and discoveries.